FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912290183> ?p ?o ?g. }

• W2912290183 endingPage "135" @default.
• W2912290183 startingPage "126" @default.
• W2912290183 abstract "Afatinib, a selective and irreversible inhibitor of tyrosine kinase, was approved for the treatment of advanced non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) overexpression in 2013. Cetuximab (CTX), an anti-EGFR monoclonal antibody, is co-administered with afatinib to improve efficacy. Unfortunately, dose-related adverse reactions caused by combination therapy have affected patient compliance, and have resulted in treatment discontinuation in severe cases. In the present study, afatinib was encapsulated in liposomes (LPs) to achieve longer circulation in the blood and an enhanced permeability-and-retention effect in tumors. Concomitantly, CTX was designed to bind to drug-loaded LPs to form immuno-LPs for tumor-cell selectivity and therapeutic activity. In vitro, the cellular internalization rate of immuno-LPs was significantly higher than that of LPs (p < 0.05). In vivo, a markedly increased area under the curve and prolonged terminal half-life were detected in rats injected with the two LP formulations, indicating that LP encapsulation protected afatinib from binding to hemoglobin to control the risk of idiosyncratic drug reactions. Compared with free afatinib and LPs, immuno-LPs exhibited strongly enhanced drug delivery and antitumor efficacy in an NSCLC xenograft model, with stronger tumor selectivity and potentially fewer side-effects. Hence, EGFR-targeting immuno-LPs appear to be promising for NSCLC treatment." @default.
• W2912290183 created "2019-02-21" @default.
• W2912290183 creator A5011042925 @default.
• W2912290183 creator A5015603864 @default.
• W2912290183 creator A5020405203 @default.
• W2912290183 creator A5021119678 @default.
• W2912290183 creator A5022609431 @default.
• W2912290183 creator A5048956159 @default.
• W2912290183 creator A5052742303 @default.
• W2912290183 creator A5052925180 @default.
• W2912290183 creator A5069618896 @default.
• W2912290183 creator A5080386307 @default.
• W2912290183 creator A5086204603 @default.
• W2912290183 date "2019-04-01" @default.
• W2912290183 modified "2023-09-30" @default.
• W2912290183 title "Afatinib-loaded immunoliposomes functionalized with cetuximab: A novel strategy targeting the epidermal growth factor receptor for treatment of non-small-cell lung cancer" @default.
• W2912290183 cites W1964977762 @default.
• W2912290183 cites W1979332174 @default.
• W2912290183 cites W2002516695 @default.
• W2912290183 cites W2003972894 @default.
• W2912290183 cites W2003984225 @default.
• W2912290183 cites W2005781928 @default.
• W2912290183 cites W2030866952 @default.
• W2912290183 cites W2056078030 @default.
• W2912290183 cites W2057145505 @default.
• W2912290183 cites W2060228539 @default.
• W2912290183 cites W2074871758 @default.
• W2912290183 cites W2094449657 @default.
• W2912290183 cites W2096198395 @default.
• W2912290183 cites W2109080255 @default.
• W2912290183 cites W2114032749 @default.
• W2912290183 cites W2129656399 @default.
• W2912290183 cites W2142865455 @default.
• W2912290183 cites W2143488876 @default.
• W2912290183 cites W2145444071 @default.
• W2912290183 cites W2152905269 @default.
• W2912290183 cites W2154149901 @default.
• W2912290183 cites W2185001055 @default.
• W2912290183 cites W2283460279 @default.
• W2912290183 cites W2299808316 @default.
• W2912290183 cites W2339713225 @default.
• W2912290183 cites W2352491315 @default.
• W2912290183 cites W2595645511 @default.
• W2912290183 cites W2744658185 @default.
• W2912290183 cites W2751866419 @default.
• W2912290183 cites W2790735851 @default.
• W2912290183 cites W2895215843 @default.
• W2912290183 cites W4237526537 @default.
• W2912290183 doi "https://doi.org/10.1016/j.ijpharm.2019.02.001" @default.
• W2912290183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30742982" @default.
• W2912290183 hasPublicationYear "2019" @default.
• W2912290183 type Work @default.
• W2912290183 sameAs 2912290183 @default.
• W2912290183 citedByCount "35" @default.
• W2912290183 countsByYear W29122901832019 @default.
• W2912290183 countsByYear W29122901832020 @default.
• W2912290183 countsByYear W29122901832021 @default.
• W2912290183 countsByYear W29122901832022 @default.
• W2912290183 countsByYear W29122901832023 @default.
• W2912290183 crossrefType "journal-article" @default.
• W2912290183 hasAuthorship W2912290183A5011042925 @default.
• W2912290183 hasAuthorship W2912290183A5015603864 @default.
• W2912290183 hasAuthorship W2912290183A5020405203 @default.
• W2912290183 hasAuthorship W2912290183A5021119678 @default.
• W2912290183 hasAuthorship W2912290183A5022609431 @default.
• W2912290183 hasAuthorship W2912290183A5048956159 @default.
• W2912290183 hasAuthorship W2912290183A5052742303 @default.
• W2912290183 hasAuthorship W2912290183A5052925180 @default.
• W2912290183 hasAuthorship W2912290183A5069618896 @default.
• W2912290183 hasAuthorship W2912290183A5080386307 @default.
• W2912290183 hasAuthorship W2912290183A5086204603 @default.
• W2912290183 hasConcept C121608353 @default.
• W2912290183 hasConcept C126322002 @default.
• W2912290183 hasConcept C139770010 @default.
• W2912290183 hasConcept C150903083 @default.
• W2912290183 hasConcept C159654299 @default.
• W2912290183 hasConcept C170493617 @default.
• W2912290183 hasConcept C185592680 @default.
• W2912290183 hasConcept C203014093 @default.
• W2912290183 hasConcept C207001950 @default.
• W2912290183 hasConcept C2776256026 @default.
• W2912290183 hasConcept C2778087573 @default.
• W2912290183 hasConcept C2779438470 @default.
• W2912290183 hasConcept C2779998722 @default.
• W2912290183 hasConcept C2780586478 @default.
• W2912290183 hasConcept C42362537 @default.
• W2912290183 hasConcept C502942594 @default.
• W2912290183 hasConcept C542903549 @default.
• W2912290183 hasConcept C71924100 @default.
• W2912290183 hasConcept C86803240 @default.
• W2912290183 hasConcept C98274493 @default.
• W2912290183 hasConceptScore W2912290183C121608353 @default.
• W2912290183 hasConceptScore W2912290183C126322002 @default.
• W2912290183 hasConceptScore W2912290183C139770010 @default.
• W2912290183 hasConceptScore W2912290183C150903083 @default.
• W2912290183 hasConceptScore W2912290183C159654299 @default.
• W2912290183 hasConceptScore W2912290183C170493617 @default.
• W2912290183 hasConceptScore W2912290183C185592680 @default.

• next